A modified human ELISPOT assay to detect specific responses to primary tumor cell targets

A modified human ELISPOT assay to detect specific responses to primary tumor cell targets

<p>Abstract</p> <p>Background</p> <p>The desired outcome of cancer vaccination is to induce a potent T cell response which can specifically recognize and eliminate autologous tumor cells <it>in vivo</it>. Accordingly, immunological assays that demonstrate re...

Full description

Bibliographic Details
Main Authors: Kwak Larry W, Baseler Michael, Troke Angela, Ulderich Tracy, Shafer-Weaver Kimberly A, Strobl Susan L, Malyguine Anatoli, Neelapu Sattva S
Format: Article
Language:English
Published: BMC 2004-03-01
Series:Journal of Translational Medicine
Online Access:http://www.translational-medicine.com/content/2/1/9

Internet

http://www.translational-medicine.com/content/2/1/9

Similar Items